Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAfter gallbladder removal, most people can consider starting Mounjaro once they have fully recovered from surgery (typically at least four to six weeks post-operatively) but the exact timing is a clinical decision that belongs with your prescriber, not a fixed rule. Mounjaro (tirzepatide) slows gastric emptying and can affect bile-flow dynamics; without a gallbladder, bile drips continuously into the intestine rather than being stored and released in controlled bursts, which changes how your digestive system handles fatty foods and some medicines. That shift doesn't automatically rule out treatment, but it does mean the timing question deserves a careful answer rather than a quick one. If you are researching this because you had your operation recently and are wondering whether tirzepatide is still an option for you, the short answer is: probably yes, but the 'when' and 'how carefully' matter, and a prescriber who knows your full history needs to make that call. Mounjaro is a prescription-only medicine; suitability is assessed individually by a GPhC-registered clinician before any prescription is issued.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The gallbladder stores bile produced by the liver and releases it in response to fatty meals. After a cholecystectomy, that reservoir is gone. Bile still flows, it just trickles continuously, without the precisely timed surge that would normally accompany a meal. For most people this causes no long-term problems, but the digestive system does need time to adjust, and some people experience looser stools, urgency or discomfort for weeks or months after surgery.
Mounjaro acts on two gut-hormone receptors (GIP and GLP-1) and one of its main effects is to slow gastric emptying: food moves out of the stomach more gradually. In a person with an intact gallbladder, that slower movement is well matched to a controlled bile release. Without a gallbladder, the slower stomach emptying meets a gut that is already managing a continuous bile drip, and that mismatch can make nausea, loose stools or abdominal discomfort more pronounced, particularly in the early weeks of treatment. This does not mean treatment is impossible, it means the titration needs to be deliberate and monitored. The relationship between Mounjaro and gallbladder health is something our prescribers assess as part of any consultation involving abdominal history.
It is also worth noting that tirzepatide (like all GLP-1 class medicines) carries a recognised risk of gallstone formation and gallbladder inflammation (cholecystitis) in people who still have a gallbladder. That risk is moot once the gallbladder is removed, which is one reason the absence of a gallbladder is not a blanket contraindication. The full Mounjaro side-effect picture is worth reading before your consultation.
Surgeons generally consider a laparoscopic cholecystectomy to have a physical recovery window of two to four weeks, but 'physical recovery' and 'digestively settled' are not the same thing. Your bowel habits, appetite and tolerance of fatty foods may take several more weeks to normalise. Starting Mounjaro while your gut is still adjusting risks layering two sources of GI disruption on top of each other, the post-surgical adjustment and the titration-phase nausea common to tirzepatide in its first few weeks.
As a rough practical benchmark, many clinicians are comfortable considering treatment from around four to six weeks after an uncomplicated laparoscopic cholecystectomy, once the patient is eating normally and has no persistent GI symptoms. Open surgery, complications or ongoing symptoms push that window out further. There is no universal figure written into Mounjaro's prescribing guidance because the SmPC does not specify a post-cholecystectomy waiting period; this is a clinical judgement, not a countdown timer.
The timing also interacts with when you plan to start. If you are hoping to begin in a particular month (say, you want treatment in place before a busy period or a holiday) factor in that the early weeks of Mounjaro often bring the most noticeable GI effects, so starting shortly before a demanding schedule is rarely ideal regardless of your surgical history. Build in time for your system to settle.
If you experience ongoing post-cholecystectomy syndrome (including persistent diarrhoea, bloating or bile-acid malabsorption) share that history clearly. A prescriber may recommend a slower titration pace or a lower starting point in that scenario, even if the standard starting dose is 2.5mg. Details on who can take Mounjaro after gallbladder removal covers the eligibility question in more depth.
Once treatment does begin, anyone without a gallbladder should be alert to digestive symptoms that go beyond the ordinary early-titration nausea. The symptoms worth acting on promptly include severe, persistent abdominal pain (particularly pain that radiates to the back or right shoulder) with or without vomiting. The MHRA highlighted acute pancreatitis as a known but infrequent serious risk with GLP-1 medicines in a Drug Safety Update published in January 2026; the symptom pattern (severe stomach pain reaching the back) overlaps with other post-surgical complications, so it should never be dismissed as routine nausea.
Other signs that need same-day or emergency attention: signs of dehydration from prolonged vomiting or diarrhoea (dark urine, dizziness, not passing urine), an allergic reaction (swelling of the face, lips or throat, difficulty breathing), or any sudden change that feels out of proportion to normal GI settling. If in doubt, call 111 or attend A&E, do not wait for a callback from an online pharmacy.
You can report any suspected side effect to the MHRA directly at yellowcard.mhra.gov.uk. That reporting scheme helps regulators track patterns across thousands of patients, and it is open to patients as well as clinicians. A guide to managing nausea and sickness on Mounjaro covers the practical steps that help most people through the early weeks.
The right question to ask is not 'has enough time passed?' in isolation, it is 'am I recovered enough, and does my prescriber have everything they need to assess me properly?' That means being ready to share the date of your surgery, the type of procedure (keyhole or open), whether you had any complications, your current digestive symptoms, any medicines you take (including bile-acid supplements if prescribed), and your general health picture.
At nume, a GPhC-registered Independent Prescriber reads your consultation personally. No algorithm flags your gallbladder history and moves on, a real clinician considers it in context. Our clinical approach is outlined on our clinical team page. The Mounjaro overview gives the broader picture of how treatment works, eligibility and what to expect, and starting Mounjaro with a gallbladder already removed looks at the specific considerations for people in exactly your situation. If you are ready to explore whether treatment is right for you now, our prescribers discuss suitability (including surgical history) as part of the free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.